Showing results (191-200 of 294) with videos related to

Sort By:
Pageof 30
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Development and Multinational Validation of a Novel Algorithmic Strategy for High Lp(a) ScreeningArya Aminorroaya, Lovedeep S Dhingra, Evangelos K Oikonomou, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studyGermán Áñez, James Hedrick, Michael W Simon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitorsV Le Moing, G Chêne, M P Carrieri, et al.
Clinical and Experimental Immunology|December 14, 2020
Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individualsN Legrand, G David, A Rodallec, et al.
HIV Medicine|August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trialJade Ghosn, P Flandre, I Cohen-Codar, et al.
The New England Journal of Medicine|October 29, 1998
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study TeamG Pialoux, F Raffi, F Brun-Vezinet, et al.
Presse Medicale (Paris, France : 1983)|August 3, 1988
[Mycoplasma pneumoniae infections. A multicenter retrospective study of 182 cases]B Garo, M Garré, J J Quiot, et al.
HIV Medicine|January 7, 2010
Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?J-J Laurichesse, A Taieb, C Capoulade-Metay, et al.
AIDS (London, England)|November 14, 1998
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral-experienced patientsF Raffi, V Reliquet, S Auger, et al.
Medecine Et Maladies Infectieuses|January 24, 2007
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort]C Brunet-François, A Taieb, B Masquelier, et al.
Pageof 30